Solvias Opens Center of Excellence for Biologics and Cell & Gene Therapy in Research Triangle Park
Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today the opening of its cutting-edge Center of ...
Finanznachrichten20d
Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development
Bora Biologics BORA BIOLOGICS LOGO "The completion of this acquisition ... in biosimilar development and commercialization at its FDA-licensed commercial-scale facility in San Diego with Bora's ...
Asian News International on MSN4d
VJ Biosciences Debuts at 5th Annual Summit of Biologics Conferences with a Bold Vision for Biopharmaceutical Innovation
New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...
MedPage Today29d
Georgia Stem Cell Companies Banned From Marketing Their Treatments
[and] provided clients with the appearance of being part of a large nationwide healthcare network under the SCIA name and logo," according ... "That year, the FDA's CBER [Center for Biologics ...
Morningstar23d
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
"The FDA approval of Omvoh may help adults with ... failure of other biologic agents prior to use. View the Omvoh brand logo. About the VIVID Clinical Trial Program VIVID-1 is a randomized ...
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...
HCW Biologics receives clearance of IND from FDA for HCW9302
HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...
Global Biologics Drug Substance Manufacturing Market to Exhibit Growth at a CAGR of ~11% by 2032 | DelveInsight
DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...
BGR7d
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...